about
The role of platelets in the recruitment of leukocytes during vascular diseaseClassification, functions, and clinical relevance of extracellular vesiclesMeasuring antiplatelet drug effects in the laboratoryMonocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface.Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defectsSizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis.Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.Short bowel syndrome and clopidogrel non-responsiveness: a new indication for platelet aggregometry?CLEC-2 expression is maintained on activated platelets and on platelet microparticles.Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality.Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over timeThe role of platelet-rich plasma in tissue regeneration.Advances in the monitoring of anti-P2Y12 therapy.Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.Testing platelet function.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayPrehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study.Vesicles in Nature and the Laboratory: Elucidation of Their Biological Properties and Synthesis of Increasingly Complex Synthetic Vesicles.Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: a systematic review.ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated?St. Anne's College, Oxford, 6-9th September 2016.Neutrophil Dysfunction, Immature Granulocytes, and Cell-free DNA are Early Biomarkers of Sepsis in Burn-injured Patients: A Prospective Observational Cohort Study.Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH.Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.Changes in the pattern of plasma extracellular vesicles after severe trauma.Platelet counting with the BD Accuri(TM) C6 flow cytometer.Microparticle sizing by dynamic light scattering in fresh-frozen plasma.Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant.Invisible vesicles swarm within the iceberg.Assessment of platelet function in the laboratory.Evaluation of the Impact-R for monitoring the platelet storage lesion.Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates.Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study.Platelet rich Plasma in Achilles Tendon Healing 2 (PATH-2) trial: protocol for a multicentre, participant and assessor-blinded, parallel-group randomised clinical trial comparing platelet-rich plasma (PRP) injection versus placebo injection for AchiParticle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing.
P50
Q26801407-A4A30E25-3AFF-44AC-8226-D5C80FEC1C7BQ27013032-8676672A-55CF-4E31-A97D-31750471CE20Q28217954-D5B81776-9E5F-4C64-B25B-BF534E6C4E5BQ30842307-7777415A-C7D8-4873-8210-E15C4E0D0CD8Q33415057-A0B280CE-833A-4619-BBDD-985EB30E920CQ33434291-C025CD81-60D6-477B-89D9-0E86FB56E50CQ33907783-0A880AE7-3895-4E1D-B481-1E487480F6B2Q34056273-7367E9C9-6237-474C-9AEC-54F3D5F9E62CQ34071552-EB01068D-6BD0-4823-8AB9-CB83C7612FA5Q34284335-537C68F8-B306-4AAF-989D-67CCB119CA0BQ34438775-8AF4DC82-696B-47E1-8787-328203CA098AQ36210410-6F939E41-81C2-49C8-9F97-FEC4285C1811Q37633382-66E794EC-3447-42D4-AD09-37FF909931FEQ38014578-C2511FE2-E2D0-4EFF-939C-899C0380C5DFQ38037121-6666F3E7-27DE-4D82-86A2-73EB147E4783Q38097973-24C5C169-01A1-43BC-8012-8AE624AC1423Q38109970-CD0D0FAE-4012-40B8-835E-70C09EA393C3Q38379177-2F5DAF7F-150D-42BB-B7C6-5B869012EBE9Q38673785-D8F05EC9-4DD1-4510-9795-089518EEEAC2Q38812366-5CD79DB1-144A-47EB-B146-61E5217E4755Q38905674-A03FC84E-9161-4D25-AFF3-754265398BF7Q39077564-C4D97B21-F419-4444-8F63-DD22CE8270C5Q39417659-548AB6C4-34B8-4E86-9F6C-465FC3FEEE74Q40453216-B43F28C0-0B09-442F-96B9-9D3255D4D3DEQ40656873-199B35DA-479C-49CC-8C81-2A7399D1CA18Q40789645-23E630A1-8164-4331-BD7F-BA38D7F103F0Q41185286-4B8202BD-0E1E-49F7-86CD-BB6AD9F7C540Q41512269-61C03E9C-3BCB-42E4-B548-3D4FBD1395A5Q44581065-66F871E8-0052-40B8-A348-E8AAECAAC2CCQ45419947-99E23E19-8BA8-43D0-A1A8-7CAD772130D1Q45872542-768A9A5A-7FC7-4E94-BD30-EB700D6B906EQ45878081-952A0A9D-53AC-440F-98B9-ABC7282AF43BQ45882682-E057E092-687F-41E2-83B9-D9493BC1756AQ45882796-023B4911-03CC-4944-8A1F-6ABBFFC19051Q46021890-953A3DBA-82B3-45F9-B054-875D04261C91Q46292951-C8E59E8B-C29A-4DD8-A5BD-E9D257C8ED02Q46292966-D7BECBF0-3CC7-4D91-88A7-0CCC6466768DQ47102704-661214BD-A792-485C-835A-EA93C80FA7D1Q47113267-43CB635B-1F96-460D-AF22-A0221CD8C880Q47173522-927F8357-F469-4C3A-AE0C-FB5749BCDDCD
P50
description
researcher ORCID: 0000-0003-4610-8909
@en
name
Paul Harrison
@ast
Paul Harrison
@en
Paul Harrison
@es
Paul Harrison
@nl
Paul Harrison
@sl
type
label
Paul Harrison
@ast
Paul Harrison
@en
Paul Harrison
@es
Paul Harrison
@nl
Paul Harrison
@sl
prefLabel
Paul Harrison
@ast
Paul Harrison
@en
Paul Harrison
@es
Paul Harrison
@nl
Paul Harrison
@sl
P106
P1153
57193361145
P21
P31
P496
0000-0003-4610-8909